Page 29 - GALENIKA MEDICAL JOURNAL

Universal screening for familial hypercholesterolemia in children: The Hypercholestero- lemia and the Use of Genetic Testing. JAMA. 2017;
Slovenian model and literature review. Atherosclerosis. 2018;277:383- 318(4):381-2.
91.
25. Sturm AC, Knowles JW, Gidding SS, Ahmad ZS, Ahmed CD, Ballantyne
16. Daniels SR, Gidding SS, de Ferranti SD; National Lipid Association CM, et al. Convened by the Familial Hypercholesterolemia Foundation.
Expert Panel on Familial Hypercholesterolemia. Pediatric aspects of Clinical Genetic Testing for Familial Hypercholesterolemia: JACC
familial hypercholesterolemias: recommendations from the National Scientific Expert Panel. J Am Coll Cardiol. 2018;72(6):662-80.
Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin
Lipidol. 2011 Jun;5(3 Suppl):S30-7. 26. Peterson AL, Bang M, Block RC, Wong ND, Karalis DG. Cascade
Screening and Treatment Initiation in Young Adults with Heterozygous
17. Roberts MC, Dotson WD, DeVore CS, Bednar EM, Bowen DJ, Ganiats Familial Hypercholesterolemia. J Clin Med. 2021;10(14):3090.
TG, et al. Delivery Of Cascade Screening For Hereditary Conditions: A
Scoping Review Of The Literature. Health Aff (Millwood). 2018;37(5):801- 27. Expert Panel on Integrated Guidelines for Cardiovascular Health
8. and Risk Reduction in Children and Adolescents; National Heart,
Lung, and Blood Institute. Expert panel on integrated guidelines for
18. Wald DS, Bestwick JP, Morris JK, Whyte K, Jenkins L, Wald NJ. Child- cardiovascular health and risk reduction in children and adolescents:
Parent Familial Hypercholesterolemia Screening in Primary Care. N Engl summary report. Pediatrics. 2011;128 Suppl 5(Suppl 5):S213-56.
J Med. 2016; 375(17):1628-37.
28. de Ferranti SD, Steinberger J, Ameduri R, Baker A, Gooding H, Kelly AS,
19. Hadfield SG, Horara S, Starr BJ, Yazdgerdi S, Marks D, Bhatnagar et al. Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A
D, et al. Steering Group for the Department of Health Familial Scientific Statement From the American Heart Association. Circulation.
Hypercholesterolaemia Cascade Testing Audit Project. Family tracing to 2019; 139(13):e603-e634.
identify patients with familial hypercholesterolaemia: the second audit
of the Department of Health Familial Hypercholesterolaemia Cascade 29. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et
Testing Project. Ann Clin Biochem. 2009;46(Pt 1):24-32. al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/
PCNA Guideline on the Management of Blood Cholesterol: A Report
20. Umans-Eckenhausen MA, Defesche JC, Sijbrands EJ, Scheerder of the American College of Cardiology/American Heart Association
RL, Kastelein JJ. Review of first 5 years of screening for familial Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019 Jun
hypercholesterolaemia in the Netherlands. Lancet. 2001;357(9251):165- 25;73(24):e285-e350.
8.
30. Leren TP, Bogsrud MP. Cascade screening for familial
21. Bell DA, Pang J, Burrows S, Bates TR, van Bockxmeer FM, Hooper hypercholesterolemia should be organized at a national level. Curr
AJ, et al. Effectiveness of genetic cascade screening for familial Opin Lipidol. 2022;33(4):231-6.
hypercholesterolaemia using a centrally co-ordinated clinical service: an
Australian experience. Atherosclerosis. 2015;239(1):93-100.
22. Jannes CE, Santos RD, de Souza Silva PR, Turolla L, Gagliardi AC,
Marsiglia JD, et al. Familial hypercholesterolemia in Brazil: cascade
screening program, clinical and genetic aspects. Atherosclerosis.
2015;238(1):101-7. Konflikt interesa: Nema
23. Tada H, Okada H, Nomura A, Nohara A, Yamagishi M, Takamura M, Primljeno: 02. 04. 2023.
Kawashiri MA. Prognostic impact of cascade screening for familial Prihvaćeno: 18. 04. 2023.
hypercholesterolemia on cardiovascular events. J Clin Lipidol.
2021;15(2):358-65. Onlajn: 01. 06. 2023.
24. Knowles JW, Rader DJ, Khoury MJ. Cascade Screening for Familial

REVIJALNI RADOVI Galenika Medical Journal, 2023; 2(6):23-27. 27